Dr. Christine Desbiens is a surgeon-oncologist at the CHU de Québec-Laval University. She is also a clinical researcher at the Research Center of the CHU de Québec-Université Laval and clinical professor at the Faculty of Medicine of Laval University. Dr. Desbiens is part of the research group of the Centre des Maladies du Sein of CHU de Québec-Laval University.

Dr. Desbiens is the leader of the Canadian Clinical Trial Group at Saint-Sacrement Hospital of the CHU de Québec. She is also the medical director for the Centre des Maladies du Sein du CHU de Québec.

Using structured breast cancer data

The Centre des Maladies du Sein research team has a comprehensive database of all cancers diagnosed since 1974; more than 12,000 patients are listed. A database of biopsy data from 1999 is also available; data on more than 34,000 biopsies are listed. These databases allow quality publications that modify the management and management of cancers and benign breast diseases.

Offer innovative treatments

The research group of the Centre des Maladies du Sein of the CHU de Québec-Laval University is one of the largest research groups in Canada offering innovative treatments for breast cancer. More than 50 clinical trials are active at all times, and are offered to patients who consult at the clinic or are referred by clinics/hospitals in the area. These clinical trials provide access to innovative experimental medications and develop the expertise of our world-renowned oncologists.

Support the quality of life

The Centre des Maladies du Sein of the CHU de Québec-Laval University research group is a pioneer in quality of life studies in breast cancer, from total mastectomy to partial mastectomy, to the use of the cooling cap to counteract hair loss, promoting physical activity to improve survivorship, including optimal preservation of the axillary lymph nodes. The research group is at the forefront of studies promoting quality of life, despite the disease’s life trial.

Hôpital Saint-Sacrement
1050, chemin Sainte-Foy
Centre des maladies du sein Deschênes-Fabia
Québec, Québec
Canada G1S 4L8

Latest news

Data not available

23 entries « 2 of 3 »

Mitera G, Earle C, Latosinsky S, Booth C, Bezjak A, Desbiens C, Delouya G, Laing K, Camuso N, Porter G

Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care.

Journal Article

J Oncol Pract, 11 (3), pp. e296-303, 2015, ISSN: 1554-7477.

Abstract | Links:

Lemieux J, Forget G, Brochu O, Provencher L, Cantin G, Desbiens C, Doyle C, Poirier B, Camden S, Durocher M

Evaluation of eligibility and recruitment in breast cancer clinical trials.

Journal Article

Breast, 23 (4), pp. 385-92, 2014, ISSN: 0960-9776.

Abstract | Links:

Poirier E, Desbiens C, Poirier B, Hogue JC, Lemieux J, Doyle C, Leblond AF, Cote I, Cantin G, Provencher L

Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients.

Journal Article

Ann Pharmacother, 48 (4), pp. 447-55, 2014, ISSN: 1060-0280.

Abstract | Links:

Hogue JC, Morais L, Provencher L, Desbiens C, Poirier B, Poirier E, Jacob S, Diorio C

Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy.

Journal Article

Anticancer Res, 34 (3), pp. 1183-91, 2014, ISSN: 0250-7005.

Abstract | Links:

Bouchard K, Chiquette J, Desbiens C, Dorval M

Mastectomie prophylactique : Expériences de femmes


CHU de Québec et Centre des maladies du sein Deschênes-Fabia, Québec, 2014.

Dorval M, Pelletier S, Bouchard K, Desbiens C, Chiquette J

[Multidisciplinary clinical management for prophylactic mastectomy: views of women from one centre in Quebec City].

Journal Article

Bull Cancer, 100 (3), pp. 201-11, 2013, ISSN: 0007-4551.

Abstract | Links:

Filion M, Forget G, Brochu O, Provencher L, Desbiens C, Doyle C, Poirier B, DuRocher M, Camden S, Lemieux J

Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.

Journal Article

Clin Trials, 9 (5), pp. 652-9, 2012, ISSN: 1740-7745.

Abstract | Links:

Provencher L, Jacob S, Cote G, Hogue JC, Desbiens C, Poirier B, Raiche I, Le Regent L, Diorio C

Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy.

Journal Article

Radiology, 263 (1), pp. 43-52, 2012, ISSN: 0033-8419.

Abstract | Links:

Larouche G, Bouchard K, Chiquette J, Desbiens C, Simard J, Dorval M

Self-reported mammography use following BRCA1/2 genetic testing may be overestimated.

Journal Article

Fam Cancer, 11 (1), pp. 27-32, 2012, ISSN: 1389-9600.

Abstract | Links:

Lemieux J, Desbiens C, Hogue JC

Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up.

Journal Article

Breast Cancer Res Treat, 128 (2), pp. 563-6, 2011, ISSN: 0167-6806.

Abstract | Links:

23 entries « 2 of 3 »
Signaler des ajouts ou des modifications

Active projects

  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31

Recently finished projects

  • NSABP Breast Cancer Treatment Protocols, Subvention, National Institute of Health (USA), Subvention de recherche, from 1997-02-01 to 2020-01-31
  • Support au service de kinésiologie au Centre des maladies du sein, Subvention, Fondation du CHU de Québec, from 2019-10-21 to 2020-03-31
  • Tomosynthesis Mammographic Imaging Screening Trial (TMIST), Subvention, L'Institut de recherche de la Société canadienne du cancer, from 2017-09-11 to 2020-03-31
Data provided by the Université Laval research projects registery